Life Technologies

Genome modulation and editing

Issue link: http://life-technologies.uberflip.com/i/438554

Contents of this Issue

Navigation

Page 26 of 66

27 Life Technologies ™ | Genome editing Figure 8. Designing target sites for customized TAL effectors for maximal binding. (A) GeneArt ® Precision TALs encode a DNA-binding protein specific to a customer-submitted sequence, fused to a FokI nuclease domain for genome editing. The sequence targeted by our first-generation TAL effectors must have a T at its 5´ end, and spacing between forward and reverse TALs must be 13–18 bp for proper pairing of the FokI nucleases and creation of a double-stranded break. (B) GeneArt ® PerfectMatch TALs eliminate the 5´ T constraint of GeneArt ® Precision TALs. GeneArt ® PerfectMatch TALs allow targeting of any sequences across the genome; 15–16 bp spacing between the two TAL effector targets is optimal for GeneArt ® PerfectMatch TALs. DNA binding domain Functional domain FokI FokI TNNNNNNNNNNNNNNNNNN NNNNNNNNNNNNNNNNNNT 13–18 bp DNA binding domain Functional domain FokI FokI NNNNNNNNNNNNNNNNNNN NNNNNNNNNNNNNNNNNNN 15–16 bp A B DNA binding domain Functional domain Fok1 Fok1 An MCS version of the GeneArt ® Precision TAL vector allows you to customize the resulting TAL fusion protein with an effector domain of your choice. Precision TALs fused to a Fok1 nuclease allow sequence- specific, double-stranded DNA breaks to be introduced. Precision TALs fused to a vp16/KRAB functional domain allow specific activation/repression of gene expression. Gene targeting (Fok1 nuclease pair) • Silencing • Incorporation of exogenous DNA Activation of transcription (Activator vp16 or vp64) • Increasing the expression level of endogenous gene isoforms Epigenetic repression of transcription (KRAB) • Heritable knockdown of gene expression Steric repression and custom design (MCS vector) • Transient knockdown of gene expression • Target any locus in the genome with the effector domain of your choice (multiple cloning site vector) Figure 7. Available effector domains

Articles in this issue

view archives of Life Technologies - Genome modulation and editing